Journal article icon

Journal article

Imaging biomarker roadmap for cancer studies

Abstract:

Imaging biomarkers (IBs) are integral to the routine management of patients with cancer. IBs used daily in oncology include clinical TNM stage, objective response and left ventricular ejection fraction. Other CT, MRI, PET and ultrasonography biomarkers are used extensively in cancer research and drug development. New IBs need to be established either as useful tools for testing research hypotheses in clinical trials and research studies, or as clinical decision-making tools for use in healthc...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1038/nrclinonc.2016.162

Authors


Cancer Research UK More from this funder
Publisher:
Nature Publishing Group Publisher's website
Journal:
Nature Reviews Clinical Oncology Journal website
Volume:
14
Issue:
3
Pages:
169–186
Publication date:
2016-01-01
Acceptance date:
2016-05-05
DOI:
EISSN:
1759-4782
ISSN:
1759-4774
Source identifiers:
620003
Pubs id:
pubs:620003
UUID:
uuid:710f322f-6638-4f10-8292-6230099f70fc
Local pid:
pubs:620003
Deposit date:
2016-05-10

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP